InsidersTradesSigma
Follow the 金域医学 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 金域医学 has recorded 3 insider filings. Market capitalisation: €12.9bn. The latest transaction was disclosed on 15 July 2024 (Purchase). Among the most active insiders: 郝必喜. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
金域医学 es una empresa especializada en servicios de diagnóstico médico y pruebas de laboratorio en China. Ofrece soluciones de salud innovadoras y de alta calidad para profesionales de la salud.